Medicine company

Precision Medicine Company adyn Raises $ 2.5 Million Seed Funding for Personalized Birth Control

Gives women personalized contraceptive recommendations to minimize side effects of medications, including blood clots and depression SEATTLE – (COMMERCIAL THREAD) – adyn, a precision medicine company, today announced it has closed a $ 2.5 million funding round. The round was co-led by Lux Capital and M13 with participation from Civilization …

Read More »

Meet Precision Medicine Company Coriell Life Sciences

New Precision medicine company Coriell Life Sciences strives to tailor treatment plans based on patients’ unique genetic makeup. Sign up to stay on top of Philly’s growing healthcare innovation scene. Photograph courtesy of Coriell Life Sciences “NextUp” is a weekly article from NextHealth PHL that highlights local leaders, organizations and …

Read More »

Women-founded telemedicine company helps women fill contraceptive prescriptions

LAS VEGAS (KLAS) – Now for some health news on why women don’t take their birth control on time. More than likely, it’s because they forget to get their prescription filled. This is the reason why Dr Sophia Yen, MD, MPH, co-founder and CEO of Pandia Health started his business. …

Read More »

MindMed will purchase HealthMode from AI Medicine Company for C $ 42 million – MIND MEDICINE MINDMED by MIND MEDICINE MINDMED INC. (MMEDF)

MindMed (NEO: MMED) (OTCQB: MMEDF) agreed to buy Health Mode, an artificial intelligence-based medicine company, in a C $ 41.56 million (US $ 32.5 million) stock and cash transaction. The psychedelic biotech company confirmed Thursday that it will acquire a digital medicine and therapeutics start-up that uses digital measurements equipped …

Read More »

Gemini Therapeutics Debut as a Listed Precision Medicine Company Focused on Age-Related Macular Degeneration

CAMBRIDGE, Mass .– (COMMERCIAL THREAD) – Gemini Therapeutics, a clinical-stage precision medicine company that develops innovative treatments for genetically defined age-related macular degeneration (AMD), today announced the completion of its combination with FS Development Corp. (Nasdaq: FSDC), a Specific Purpose Acquisition (SPAC) sponsored by Foresite Capital. Gemini Therapeutics, Inc., the …

Read More »